Pancreatic ductal adenocarcinoma: Eleven years of experience at a tertiary care hospital center
Introduction and aim: Pancreatic cancer is considered one of the most aggressive solid tumors. In Mexico, it is the twelfth cause of cancer, with 4,489 cases diagnosed annually, and accounts for 4.9% of oncologic deaths. Aim: The aim of our study was to describe the clinical and epidemiologic charac...
Main Authors: | G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Revista de Gastroenterología de México (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2255534X21000189 |
Similar Items
-
Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
by: Hongbeom Kim, et al.
Published: (2020-06-01) -
Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
by: Graziana Gallo, et al.
Published: (2020-04-01) -
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
by: Tarak Chouari, et al.
Published: (2023-08-01) -
Quantitative indexes of stromal markers expression in the pancreatic ductal adenocarcinoma and chronic pancreatitis
by: V. A. Tumanskiy, et al.
Published: (2015-08-01) -
Translocation of Oral Microbiota into the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment
by: Kelley N. L. McKinley, et al.
Published: (2023-05-01)